APA (7th ed.) Citation

Diamond, T., Lau, M., Morrissette, J., Chu, N., & Behrens, E. M. (2023). CXCL9 inhibition does not ameliorate disease in murine models of both primary and secondary hemophagocytic lymphohistiocytosis. Nature Portfolio.

Chicago Style (17th ed.) Citation

Diamond, Tamir, Michelle Lau, Jeremy Morrissette, Niansheng Chu, and Edward M. Behrens. CXCL9 Inhibition Does Not Ameliorate Disease in Murine Models of Both Primary and Secondary Hemophagocytic Lymphohistiocytosis. Nature Portfolio, 2023.

MLA (9th ed.) Citation

Diamond, Tamir, et al. CXCL9 Inhibition Does Not Ameliorate Disease in Murine Models of Both Primary and Secondary Hemophagocytic Lymphohistiocytosis. Nature Portfolio, 2023.